Sign In
Buy PET
$0.0469
+0 (+0%)
At Close: Oct 28, 2025
First Origin PET Caps in Stores with Power Hydration Pilot Launch
04:01pm, Thursday, 14'th Aug 2025
WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin”) (Nasdaq: ORGN, ORGNW), today announced the first Origin PET caps in stores. Origin partnered with Power Hydration, a new
Eurazeo Enters Into Exclusive Discussions With INSPIRED PET NUTRITION Regarding the Sale of Its Stake in Ultra Premium Direct
11:40am, Thursday, 14'th Aug 2025
PARIS & LONDON--(BUSINESS WIRE)--Eurazeo has entered into exclusive discussions with INSPIRED PET NUTRITION (“IPN”), the fast-growing international pet food company controlled by CapVest Partners
Ongoing Joint Clinical Study Could Pave the Way for Testing Efficacy of Quantum's Investigational MS drug, Lucid-21-302 Ongoing Joint Clinical Study Could Pave the Way for Testing Efficacy of Quantum'
Origin Materials Announces Strategic Customer Relationship with Berlin Packaging for Sustainable PET Bottlecaps
07:00am, Tuesday, 05'th Aug 2025
WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials, Inc. (“Origin”) (NASDAQ: ORGN, ORGNW), a technology company with a mission to enable the world's transition to sustainable materials, an
Pet Valu Reports Second Quarter 2025 Results
06:30am, Tuesday, 05'th Aug 2025
Delivers 2.6% Same-Store Sales Growth(1), 6% Revenue Growth Raises 2025 Outlook and Announces Chief Executive Officer Succession Plan MARKHAM, Ontario, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pet Valu Holdi
Origin Materials and Hordijk to Mass Produce PET Bottlecaps
07:00am, Tuesday, 29'th Jul 2025
WEST SACRAMENTO, Calif.--(BUSINESS WIRE)--Origin Materials (“Origin”) (NASDAQ: ORGN, ORGNW), a technology company with a mission to enable the world's transition to sustainable materials, and Roya
CARBIOS enters the r-PET market for tire textile filaments
11:45am, Monday, 21'st Jul 2025
Clermont-Ferrand (France), 21 July 2025 (17h45 CEST) – CARBIOS (Euronext Growth Paris: ALCRB) announces the signing of a multi-year commercial agreement with Indorama Ventures, the global leader i
Wag! Group Co. Announces Recapitalization Transaction with Retriever LLC
06:00am, Monday, 21'st Jul 2025
Initiates Chapter 11 Proceeding via Pre-Packaged Plan of Reorganization Operations Across Business Segments to Continue Without Interruption During Chapter 11 Process and Beyond SAN FRANCISCO, July 21
Pet Valu Announces Timing of Second Quarter 2025 Earnings Release
07:05am, Thursday, 10'th Jul 2025
MARKHAM, Ontario, July 10, 2025 (GLOBE NEWSWIRE) -- Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), the leading Canadian specialty retailer of pet food and pet-related supplie
Contineum Therapeutics Provides Update on Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
08:15am, Wednesday, 25'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--FDA approves expanded indications for GE HealthCare's Vizamyl PET imaging agent for beta amyloid detection, enabling more precise care for Alzheimer's.
GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging
12:00pm, Tuesday, 24'th Jun 2025
GEHC's Flyrcado gains momentum with FDA approval, CMS support, and expanding coverage in cardiac PET imaging.
Pioneering precision: GE HealthCare aims to elevate clinical care through total body PET/CT technology with Stanford Medicine
12:00pm, Thursday, 19'th Jun 2025
CHICAGO--(BUSINESS WIRE)--Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research collaboration with Stanford Medicine – with one of their key intentio
CARBIOS signs its first biorecycled PET sales contracts with two global cosmetics leaders
11:45am, Tuesday, 27'th May 2025
Clermont-Ferrand (France), 27 May 2025 (17.45 CEST). CARBIOS (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycl
VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare an
